Regulation of C-type natriuretic peptides and natriuretic peptide receptor-B expression in diabetic rats renal treated by Tongluo Recipe (通络方)
Tóm tắt
To investigate the expression of C-type natriuretic peptides (CNP) and natriuretic peptide receptor-B (NPR-B) receptor in diabetic rats renal cortex, and the regulation by Tongluo Recipe (通络方, TLR). Sixty male SD rats were divided into 3 groups: the normal control group, diabetic model group and diabetic TLR group. Each group was further divided into two subgroups of ten in each, according to 4-week or 12-week observation period. Streptozotocin (STZ)-induced diabetic rats were treated with TLR (1.0 g·kg−1·d−1) for 4 and 12 weeks, respectively. (1) The essential information was collected for comparing renal mass, serum creatinine and 24 h urine albumen on each group was calculated. (2) CNP mRNA and NPR-B mRNA were detected by realtime-polymerase chain reaction (PCR) on rats renal cortex. (3) Concentration of CNP on renal cortex or serum were analyzed by enzyme-linked immunosorbent assay (ELISA). (4) Pathological evaluation and NPR-B immunostaining for renal tissue were also performed. (1) CNP and NPR-B mRNA levels were detected in each treated or untreated group, with slight elevated in untreated diabetes rats administrated with STZ after 4-week and CNP mRNA level remarkable elevated at 39.21 times higher than normal control group after 12 weeks, but NPR-B mRNA level showed a remarkably down-regulation at 98.07% after 12 weeks. CNP mRNA of TLR-treated group was also elevated after 12-week treatment, but less than untreated group. (2) Concentrations of CNP in renal cortex were obviously increased in treated or untreated diabetes rats, within these groups the treatment of TLR was found more significantly on prompting CNP concentration. Comparing to normal group, serum concentrations of CNP were also increased in treated or untreated diabetic groups, but there was no difference between these diabetic groups. (3) Renal lesions like glomerular volume increased are observed mostly in the relative early stage after 4 weeks. Although TLR treated group had no significant difference in their glomerular volume, the degrees of injury of glomerulus were ameliorated, as well as the NPR-B immunostaining enhanced in glomerulus. Weakly positive immunostaining of NPR-B are observed in glomerulus of normal control, and negative in glomerulus of untreated diabetes rats administrated with STZ after 12 weeks, whereas TLR-treatment groups showed a little enhancement. CNP and NPR-B showed different characteristic on renal cortex at different pathological period in diabetes rats, and TLR regulated their expression.
Tài liệu tham khảo
Qu W, Zou JJ, Shi YQ, Zhang CY, Liu ZM. Influence of C-type natriuretic peptide on expression of natriuretic peptide B receptor suppressed by advanced glycation end products and on post-receptor signal regulation. Acad J Sec Mil Med Univ (Chin) 2007;28:758–760.
Hirose K, Osterby R, Nozawa M, Gundersen HJ. Development of glomerular lesions in experimental longterm diabetes in the rat. Kidney Int 1982;21:689–695.
Lin L, Guo XZ, Li M, Gong YB, Wang B, Liu Y. Analysis on relationship of Chinese medicine syndrome pattem with urinary albumin excretion rate and its related factors in early stage diabetic nephropathy. Chin J Integr Tradit West Med (Chin) 2010;30:912–914.
Zhang CY, Zou JJ, Shi YQ, Qu W, Sun LL, Liu ZM. Effect of Tongluo Recipe on oxidative stress in kidneys of diabetic rats. Acad J Sec Mil Med Univ (Chin) 2008;29:940–943.
Zhang CY, Zou JJ, Shi YQ, Xia L, Wang HQ, Chen F, et al. Inhibitory effect of Tongluo recipe on glomerular endothelium proliferation in diabetic rats. Acad J Sec Mil Med Univ (Chin) 2009;30:727–730.
Zhang LY, Zou JJ, Feng XY, Liu ZM. Effects of Tongluo Recipe on proliferation and oxidative stress of rat glomerular mesangial cells under high glucose. Chin J Cell Biol (Chin) 2010;32:579–584.
Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors and cGMP-dependent signaling functions. Endocrine Rev 2005;16:er2005–0014.
Hu P, Lu L, Hu B, Qin YH. Renal action of C-type natriuretic peptide: Advocating the isolated perfused rat kidney model. Saudi J Kidney Dis Transpl 2010;21:613–620.
Woodard GE, Li XH, Rosado JA. Characteristics of the renal C-type natriuretic peptide receptor in hypertrophied and developing rat kidney. J Mol Endocrinol 2005;35:519–530.
Lai KN, Leung JC, Yandle TG, Fisher S, Nicholls MG. Gene expression and synthesis of natriuretic peptide by cultured human glomrular. Hypertens 1999;17:575–583.
Lewko B, Endlich N, Kriz W, Stepinski J, Endlich K. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress. Kidney International 2004;66:1001–1008.
Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991;252:120–123.
Simon A, Harrington EO, Liu GX, Koren G, Choudhary G. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization. Am J Physiol Lung Cell Mol Physiol 2009;296:248–256.
Villar IC, Panayiotou CM, Sheraz A, Madhani M, Scotland RS, Nobles M, et al. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc Res 2007;74:515–525.
Chauhan SD, Hobbs AJ, Ahluwalia A. C-t y p e natriuretic peptide: new candidate for endotheliumderived hyperpolarising factor. Int J Biochem Cell Biol 2004;36:1878–1881.
Walther T, Schuitheiss HP, Tschöpe C. Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus. Cardiovas Res 2001;51:562–566.
Feletou M, Vanhoutte PM. EDHF: new therapeutic targets. Pharmacol Res 2004;49:565–580.